SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008736
Filing Date
2017-08-09
Accepted
2017-08-09 14:51:38
Documents
34
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 381387
2 ex10-6.htm EX-10.6 11742
3 ex31-1.htm EX-31.1 18267
4 ex31-2.htm EX-31.2 18217
5 ex32.htm EX-32 7506
  Complete submission text file 0001493152-17-008736.txt   1554101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pvct-20170630.xml EX-101.INS 139880
7 XBRL SCHEMA FILE pvct-20170630.xsd EX-101.SCH 18785
8 XBRL CALCULATION FILE pvct-20170630_cal.xml EX-101.CAL 26232
9 XBRL DEFINITION FILE pvct-20170630_def.xml EX-101.DEF 72430
10 XBRL LABEL FILE pvct-20170630_lab.xml EX-101.LAB 145955
11 XBRL PRESENTATION FILE pvct-20170630_pre.xml EX-101.PRE 107654
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 171017524
SIC: 2834 Pharmaceutical Preparations